Contraceptives -- Developing countries

See also what's at your library, or elsewhere.

• Contraceptives
• Developing countries

• Contraceptives -- Developing countries -- Marketing
• Contraceptives -- Developing countries -- Statistics

• Development assistance : issues concerning AID's social marketing for change program : report to the Honorable William V. Roth, Jr., U.S. Senate / United States General Accounting Office. (Washington, D.C. : The Office, 1988) (page images at HathiTrust)

• Trends in adolescent fertility and contraceptive use in the developing world / by Thomas M. McDevitt with Arjun Adlakha, Timothy B. Fowler and Vera Harris-Bourne. (Washington, DC : U.S. Dept. of Commerce, Economics and Statistics Administration, Bureau of the Census, [1996]), by Thomas M. McDevitt (page images at HathiTrust)

Items below (if any) are from related and broader terms.

• Comparing contraceptives / by Judith Willis. (Rockville, Md. : Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Office of Public Affairs, 1986), by Judith Willis (page images at HathiTrust)
• A self-instructional booklet to aid in the understanding of contraception. (Rockville, Md. : U.S. Dept. of Health, Education, and Welfare, Public Health Service, Health Services Administration, Bureau of Community Health Services, 1976), by United States. Health Services Administration. Bureau of Community Health Services (page images at HathiTrust)
• FDA's approval of the Today contraceptive sponge hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, July 13, 1983. (Washington : U.S. G.P.O., 1984), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)
• Fertility and contraception in America hearings before the Select Committee on Population, Ninety-fifth Congress, second session ... (Washington : U. S. Govt. Print. Off., 1978-), by United States. Congress. House. Select Committee on Population (page images at HathiTrust)
• World population and fertility planning technologies : the next 20 years. (Washington, D.C. : Congress of the U.S., Office of Technology Assessment : For sale by the Supt. of Docs., U.S. G.P.O., 1982-) (page images at HathiTrust)
• Reproductive, maternal and child health in Eastern Europe and Eurasia : a comparative report / Division of Reproductive Health, Centers for Disease Control and Prevention, ORC MACRO DHS. (Atlanta, GA : U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, [2003]) (page images at HathiTrust)

• Reproductive health survey Azerbaijan, 2001 : final report / edited by Florina Serbanescu ... [et al.] ; Adventist Development and Relief Agency (ADRA) ... [et al.] ; Division of Reproductive Health, Centers for Disease Control and Prevention (DRH/CDC). (Atlanta, GA : U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, [2003]) (page images at HathiTrust)

• Family Planning: A Global Handbook for Providers, by World Health Organization, Information and Knowledge for Optimal Health Project, and United States Agency for International Development Office of Population and Reproductive Health (PDF with commentary at k4health.org)

• AID's experience with contraceptive social marketing : a synthesis of project findings / Annette L. Bennendijk. (Washington, D.C. : Agency for International Development, 1986), by Annette L. Binnendijk (page images at HathiTrust)

• Contraceptive Use and Controlled Fertility: Health Issues for Women and Children, ed. by Allan M. Parnell (page images at NAP)

• Norplant and contraceptive pricing : conflict of interest, protection of public ownership in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1994-), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)

• Developing New Contraceptives: Obstacles and Opportunities, ed. by Luigi Mastroianni, Peter J. Donaldson, and Thomas T. Kane (page images at NAP)
• Contraceptive technology : hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment of the Committee on Science and Technology, U.S. House of Representatives, Ninety-ninth Congress, first session, April 23, 1985. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O., 1986), by Agriculture Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Natural Resources (page images at HathiTrust)

• Developing New Contraceptives: Obstacles and Opportunities, ed. by Luigi Mastroianni, Peter J. Donaldson, and Thomas T. Kane (page images at NAP)

• The Walnut Creek contraceptive drug study : a prospective study of the side effects of oral contraceptives / edited by Savitri Ramcharan. (Bethesda, Md. : U.S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Institute of Child Health and Human Development, Center for Population Research ; Washington : for sale by the Supt. of Docs., U.S. Govt. Print. Off., [1974-) (page images at HathiTrust)

• FDA's approval of the Today contraceptive sponge : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, July 13, 1983. (Washington : U.S. G.P.O. : [For sale by the Supt. of Docs., U.S. G.P.O., Congressional Sales Office], 1984), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)

• FDA's approval of the Today contraceptive sponge : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, July 13, 1983. (Washington : U.S. G.P.O. : [For sale by the Supt. of Docs., U.S. G.P.O., Congressional Sales Office], 1984), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)

• Family Planning Amendments of 1989 : report together with additional views (to accompany S. 110). ([Washington, D.C.? : U.S. G.P.O., 1989]), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
• Family planning clinics : strain of Norplant's high up-front costs has subsided : report to the Chairman, Subcommittee on Regulation, Business Opportunities, and Technology, Committee on Small Business, House of Representatives / United States General Accounting Office. (Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1994]), by United States General Accounting Office (page images at HathiTrust)

• Impact of the high-cost of long-term contraceptive products on federally sponsored family planning clinics, welfare reform efforts, and women's health initiatives : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, March 18, 1994. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1994), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)

• The depo-provera debate hearings before the Select Committee on Population, U.S. House of Representatives, Ninety-fifth Congress, second session, August 8, 9, and 10, 1978. (Washington : U.S. Govt. Print. Off., 1978), by United States. Congress. House. Select Committee on Population (page images at HathiTrust)

• Equity in Prescription Insurance and Contraceptive Coverage Act : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, second session, on S. 766 ... July 21, 1998. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1998), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)

• The Depo-Provera debate : hearings before the Select Committee on Population, U.S. House of Represetatives, Ninety-fifth Congress, second session, August 8, 9, and 10, 1978. (Washington : U.S. Govt. Print. Off., 1978. [i.e. 1979]), by United States. Congress. House. Select Committee on Population (page images at HathiTrust)

• Report on the oral contraceptives. ([Washington], [s.n.]), by United States. Advisory Committee on Obstetrics and Gynecology (page images at HathiTrust)
• Quality of scientific evidence in FDA regulatory decisions the adoption of an antismoking warning in oral contraceptive pill labeling : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fifth Congress, second session, October 4, 1978. (Washington : U.S. Govt. Print. Off., 1978), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)
• Oral contraceptives and estrogens for postmenopausal use, 1976 : joint hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, second session ... January 21, 1976. (Washington : U.S. Govt. Print. Off. : [For sale by the Supt. of Docs., U.S. G.P.O., Congressional Sales Office], 1976), by United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health (page images at HathiTrust)
• Competitive problems in the drug industry the risks and benefits of oral contraceptives : summary and analysis / Select Committee on Small Business, United States Senate, Subcommittee on Monopoly and Anticompetitive Activities ; prepared by the Congressional Research Service, Library of Congress. (Washington : U.S. G.P.O., 1978), by Vikki A. Zegel (page images at HathiTrust)

• Competitive problems in the drug industry the risks and benefits of oral contraceptives : summary and analysis / Select Committee on Small Business, United States Senate, Subcommittee on Monopoly and Anticompetitive Activities ; prepared by the Congressional Research Service, Library of Congress. (Washington : U.S. G.P.O., 1978), by Vikki A. Zegel (page images at HathiTrust)

• Does the Birth Control Pill Cause Abortions? (10th edition; Sandy, OR: Eternal Perspective Ministries, 2011), by Randy C. Alcorn (PDF with commentary at epm.org)

• The Walnut Creek contraceptive drug study : a prospective study of the side effects of oral contraceptives / edited by Savitri Ramcharan. (Bethesda, Md. : U.S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Institute of Child Health and Human Development, Center for Population Research ; Washington : for sale by the Supt. of Docs., U.S. Govt. Print. Off., [1974-) (page images at HathiTrust)
• Competitive problems in the drug industry the risks and benefits of oral contraceptives : summary and analysis / Select Committee on Small Business, United States Senate, Subcommittee on Monopoly and Anticompetitive Activities ; prepared by the Congressional Research Service, Library of Congress. (Washington : U.S. G.P.O., 1978), by Vikki A. Zegel (page images at HathiTrust)

• Oral Contraceptives and Breast Cancer (1991), by Institute of Medicine (U.S.) (page images with commentary at NAP)

• RU-486 : demonstrating a low standard for women's health? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, May 17, 2006. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007), by Drug Policy United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice (page images at HathiTrust)

• Evaluation of R-55 and Mestranol to protect douglas-fir seed from deer mice / by Glenn R. Crouch and M.A. Radwan. (Portland, Ore. : Pacific Northwest Forest and Range Experiment Station, Forest Service, U.S. Dept. of Agriculture, 1971), by Glenn LeRoy Crouch (page images at HathiTrust; US access only)

• RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1994), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
• The effect of federal ban of RU 486 on medical research, new drug development, and pharmaceutical manufacturers : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Washington, DC, July 28, 1992. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1993), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)

• The safety and effectiveness of the abortifacient RU486 in foreign markets : opportunities and obstacles to U.S. commercialization : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, first session, Washington, DC, December 5, 1991. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., [Congressional Sales Office], 1992), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)

• RU-486, status report on the U.S. commercialization project, transfer of antiprogestin technology to the United States : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 16, 1994. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1994), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
• The effect of federal ban of RU 486 on medical research, new drug development, and pharmaceutical manufacturers : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Washington, DC, July 28, 1992. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1993), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
• RU 486 : the import ban and its effect on medical research : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred First Congress, second session, Washington, DC, November 19, 1990. (Washington : U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O., 1991), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
• The safety and effectiveness of the abortifacient RU486 in foreign markets : opportunities and obstacles to U.S. commercialization : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, first session, Washington, DC, December 5, 1991. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., [Congressional Sales Office], 1992), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)

• The Depo-Provera debate : hearings before the Select Committee on Population, U.S. House of Represetatives, Ninety-fifth Congress, second session, August 8, 9, and 10, 1978. (Washington : U.S. Govt. Print. Off., 1978. [i.e. 1979]), by United States. Congress. House. Select Committee on Population (page images at HathiTrust)

• The Depo-Provera debate : hearings before the Select Committee on Population, U.S. House of Represetatives, Ninety-fifth Congress, second session, August 8, 9, and 10, 1978. (Washington : U.S. Govt. Print. Off., 1978. [i.e. 1979]), by United States. Congress. House. Select Committee on Population (page images at HathiTrust)

• Impact of the high-cost of long-term contraceptive products on federally sponsored family planning clinics, welfare reform efforts, and women's health initiatives : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, March 18, 1994. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1994), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)

• Family planning clinics : strain of Norplant's high up-front costs has subsided : report to the Chairman, Subcommittee on Regulation, Business Opportunities, and Technology, Committee on Small Business, House of Representatives / United States General Accounting Office. (Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1994]), by United States General Accounting Office (page images at HathiTrust)

• Norplant and contraceptive pricing : conflict of interest, protection of public ownership in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session. (Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1994-), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
• Family planning clinics : strain of Norplant's high up-front costs has subsided : report to the Chairman, Subcommittee on Regulation, Business Opportunities, and Technology, Committee on Small Business, House of Representatives / United States General Accounting Office. (Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1994]), by United States General Accounting Office (page images at HathiTrust)

• Regulation of medical devices (intrauterine contraceptive devices) Hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-third Congress, first session. (Washington : U.S. Govt. Print. Off., 1973), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee (page images at HathiTrust)
• On the use and abuse of pessaries. (London, Lewis, 1884), by George Granville Bantock (page images at HathiTrust; US access only)
• IUDs : guidelines for informed decision-making and use : developed from a meeting held at the Centers for Disease Control on September 11, 1986. (Atlanta, Ga. : U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education, 1987) (page images at HathiTrust)

More items available under broader and related terms at left.